Cyproterone
Trade name: Androcur
Small moleculeexperimental
Cyproterone, also known by its developmental code name SH-80881, is a steroidal antiandrogen which was studied in the 1960s and 1970s but was never introduced for medical use. It is a precursor of cyproterone acetate (CPA), an antiandrogen, progestin, and antigonadotropin which was introduced instead of cyproterone and is widely used as a medication. Cyproterone and CPA were among the first antiandrogens to be developed. — Wikipedia
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Aug 1, 2017 (NCT03236740)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Androgen ReceptorINHIBITOR
AR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCyproterone ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04590417 | N/A | Oct 1, 2020 | Thai Red Cross AIDS Research Centre, Bangkok, Thailand |
| NCT04848181 | Early Phase 1 (Phase 1) | Jul 1, 2019 | Benha University |
| NCT03236740 | Phase 4 | Aug 1, 2017 | SCB Medical College, Cuttack |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Benha University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| SCB Medical College, Cuttack | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Thai Red Cross AIDS Research Centre, Bangkok, Thailand | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1